Together, these data indicate that during pancreatic cancer development, AGO2 localizes at the plasma membrane, the site of RAS activity2,28, and substantiates a role for AGO2 in the progression of PanINs to PDAC. Here, AGO2 is linked to familial pancreatic carcinoma.